Evidence map›Paper›PMID 32808927›Full record

ArticleeLife2020

TBX3 acts as tissue-specific component of the Wnt/β-catenin transcriptional complex.

Dario Zimmerli, Costanza Borrelli, Amaia Jauregi-Miguel, Simon Söderholm, Salome Brütsch, Nikolaos Doumpas, Jan Reichmuth, Fabienne Murphy-Seiler, MIchel Aguet, Konrad Basler and 2 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. TRIAGE: an R package for regulatory gene analysis.Briefings in bioinformatics · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Wnt signaling regulates hepatocyte cell division by a transcriptional repressor cascade.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Dario Zimmerli *Department of Molecular Life Sciences, University of Zurich, Zürich, Switzerland.
Costanza Borrelli *Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.
Amaia Jauregi-Miguel *Wallenberg Centre for Molecular Medicine, Linköping University, Linköping, Sweden.ORCID 0000-0003-0938-7734
Simon SöderholmWallenberg Centre for Molecular Medicine, Linköping University, Linköping, Sweden.ORCID 0000-0001-5350-7102
Salome BrütschDepartment of Molecular Life Sciences, University of Zurich, Zürich, Switzerland.
Nikolaos DoumpasDepartment of Molecular Life Sciences, University of Zurich, Zürich, Switzerland.
Jan ReichmuthDepartment of Molecular Life Sciences, University of Zurich, Zürich, Switzerland.
Fabienne Murphy-SeilerSwiss Institute for Experimental Cancer Research (ISREC), Ecole Polytechnique Fédérale de Lausanne (EPFL), School of Life Sciences, Lausanne, Switzerland.
MIchel AguetSwiss Institute for Experimental Cancer Research (ISREC), Ecole Polytechnique Fédérale de Lausanne (EPFL), School of Life Sciences, Lausanne, Switzerland.
Konrad BaslerDepartment of Molecular Life Sciences, University of Zurich, Zürich, Switzerland.
Andreas E MoorDepartment of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.ORCID 0000-0001-8715-8449
Claudio CantùWallenberg Centre for Molecular Medicine, Linköping University, Linköping, Sweden.ORCID 0000-0003-1547-5415
University of Zurich · CHLinköping University · SEÉcole Polytechnique Fédérale de Lausanne · CHETH Zurich · CH

Funding

Cancerfonden CAN 2018/542Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung PCEPP3_181249
6 · The paper itself

Abstract

BCL9 and PYGO are β-catenin cofactors that enhance the transcription of Wnt target genes. They have been proposed as therapeutic targets to diminish Wnt signaling output in intestinal malignancies. Here we find that, in colorectal cancer cells and in developing mouse forelimbs, BCL9 proteins sustain the action of β-catenin in a largely PYGO-independent manner. Our genetic analyses implied that BCL9 necessitates other interaction partners in mediating its transcriptional output. We identified the transcription factor TBX3 as a candidate tissue-specific member of the β-catenin transcriptional complex. In developing forelimbs, both TBX3 and BCL9 occupy a large number of Wnt-responsive regulatory elements, genome-wide. Moreover, mutations in

Indexed as

Wnt Signaling PathwayAnimalsFemaleHCT116 CellsHumansMaleMiceOrgan SpecificityT-Box Domain ProteinsTranscription FactorsTumor Cells, CulturedZebrafishBCL9 protein, mouseT-Box Domain ProteinsTBX3 protein, humanTbx3 protein, mouseTranscription Factorscolorectal cancerdevelopmentdevelopmental biologygene regulationlimb developmentmousetranscriptionwnt signallingzebrafish

Identifiers

PMID32808927
PMCPMC7434441
OpenAlexW3056694453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.